critically ill subpopulations. [7] [8] [9] [10] The adequacy and appropriateness of fluid therapy (crystal loids and colloids) for cardiac patients is high ly debatable, and it is suggested that more va sopressors, inotropes, and mechanical support should be used instead. 12 From this point of view, the significance of positive FB in critically ill pa tients could not be judged by this highly select ed population in which most patients suffered from cardiovascular disease as a cause of the ICU treatment. It is also worth mentioning that the authors did not present data on catecholamine administration, acute renal and respiratory dys function, and other types of shock.
Trejnowska et al 11 highlighted in their study that even a minor quantity of positive FB might be associated with an increased risk of death in cardiac critically ill patients. Those findings are in line with a previous paper by Boyd et al, 13 who also demonstrated that a more positive FB (more than 3 liters at 12 hours), both early in resuscitation and cumulatively over 4 days, was associated with an increased risk of mortali ty in septic shock. Trejnowska et al 11 reported that the main difference in cumulative positive daily FB between survivors and nonsurvivors was about 1 liter of fluids during the first 72 hours of the ICU stay (see Figure 1 in the orig inal paper). This is a small positive FB that might be considered negligible and might not require resuscitation in patients with trauma and sepsis but might be detrimental for those with significant cardiovascular and respirato ry compromise.
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Fluid therapy in the intensive care unit (ICU) re mains controversial and creates a difficult dilem ma. The rationale for fluid administration in sep sis and trauma is based on the presence of prima ry or secondary hypovolemia due to volume loss, severe vasodilation, capillary leak, and third space losses. 1, 2 The main aim of early fluid treat ment is to achieve an acceptable volemic state (central venous pressure, 8-10 mm Hg for non ventilated persons). Thus, early aggressive flu id resuscitation has resulted in a significant im provement in clinical outcome of critically ill pa tients with sepsis and trauma. 1,2 Therefore, it is not surprising that a very large positive fluid bal ance (FB) is a common finding in this population.
However, this statement is not true for ev eryone. Even slight cumulative positive FB may in itself be harmful and can worsen respiratory function, 3,4 associated with increased mortality in patients with acute renal failure 4-7 and cardi ac in critically ill subpopulations. [7] [8] [9] [10] On the same topic, in the current issue of Kardiologia Polska (Kardiol Pol, Polish Heart Journal), Trejnowska et al 11 published a retrospective, ob servational survey of the importance of posi tive FB in critically ill patients. The study was conducted between January 2012 to Decem ber 2016 in 2 ICUs of Silesian Center for Heart Disease in Poland, including a total of 495 pa tients admitted to both ICUs. The overwhelm ing majority of them were patients with cardio vascular and respiratory compromise. The au thors found a strong correlation between cu mulative positive FB and increased mortality in cardiac critically ill patients. 11 The predom inance of critically ill patients with cardiovas cular disorders in the present study is very im portant in that the significance of fluid man agement is different for cardiac and noncardiac OPEN ACCESS This is an Open Access article distributed under the terms of the Creative Commons Attribution -NonCommercial -NoDerivatives 4.0 International License (CC BY -NC -ND 4.0), allowing third parties to download articles and share them with others, provided the original work is properly cited, not changed in any way, distributed under the same license, and used for noncommercial purposes only. For commercial use, please contact the journal office at kardiologiapolska@ptkardio.pl. 
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